Bimatoprost ophthalmic and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Bimatoprost ophthalmic and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bimatoprost ophthalmic
Brand name: Lumigan
Synonyms: Bimatoprost
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bimatoprost ophthalmic-Insulin degludec
- Bimatoprost ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Bimatoprost ophthalmic-Insulin Degludec (U-100) Vials
- Bimatoprost ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Bimatoprost ophthalmic-Insulin degludec and liraglutide
- Bimatoprost ophthalmic-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Bimatoprost Ophthalmic Solution
- Insulin aspart, recombinant Subcutaneous-Bimatoprost topical ophthalmic
- Insulin aspart, recombinant Subcutaneous-Binimetinib
- Insulin aspart, recombinant Subcutaneous-Binora Topical
- Insulin aspart, recombinant Subcutaneous-Binosto
- Insulin aspart, recombinant Subcutaneous-Bio Glo